Child-Parent Familial Hypercholesterolemia Screening

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-3
SponsorChildren's Hospital of Fudan University

About this trial

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice.

key scientific questions:

1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.

Eligibility criteria

Qualifiers

Receive routine child care

aged 1 - 3 years old ( date of investigate minus date of birth)

Disqualifiers

It is up to the researcher to decide whether it is suitable to participate in this research

Trial design

Treatments tested in this trial

  • no interventions

Treatment groups

No treatment groups listed